Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Interest Coverage Ratio (2020 - 2025)

Barinthus Biotherapeutics (BRNS) has disclosed Interest Coverage Ratio for 6 consecutive years, with 1158.92 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Coverage Ratio fell 110.04% year-over-year to 1158.92, compared with a TTM value of 1647.6 through Sep 2025, down 22.48%, and an annual FY2024 reading of 1282.45, up 57.21% over the prior year.
  • Interest Coverage Ratio was 1158.92 for Q3 2025 at Barinthus Biotherapeutics, up from 1943.67 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 8.84 in Q1 2022 and bottomed at 2855.43 in Q4 2023.
  • Average Interest Coverage Ratio over 5 years is 1506.33, with a median of 1554.22 recorded in 2024.
  • The sharpest move saw Interest Coverage Ratio skyrocketed 76.02% in 2024, then crashed 110.04% in 2025.
  • Year by year, Interest Coverage Ratio stood at 926.0 in 2021, then soared by 100.95% to 8.84 in 2022, then crashed by 32409.13% to 2855.43 in 2023, then skyrocketed by 31.74% to 1949.17 in 2024, then skyrocketed by 40.54% to 1158.92 in 2025.
  • Business Quant data shows Interest Coverage Ratio for BRNS at 1158.92 in Q3 2025, 1943.67 in Q2 2025, and 1584.62 in Q1 2025.